Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Andrea Scozzafava, Claudiu T. Supuran, Fabrizio Carta
Expert Opinion on Therapeutic Patents (2013) Vol. 23, Iss. 6, pp. 725-735
Closed Access | Times Cited: 260

Showing 1-25 of 260 citing articles:

Structure and function of carbonic anhydrases
Claudiu T. Supuran
Biochemical Journal (2016) Vol. 473, Iss. 14, pp. 2023-2032
Closed Access | Times Cited: 781
How many carbonic anhydrase inhibition mechanisms exist?
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2015) Vol. 31, Iss. 3, pp. 345-360
Open Access | Times Cited: 676
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
Chuang Zhao, K.P. Rakesh, L. Ravidar, et al.
European Journal of Medicinal Chemistry (2018) Vol. 162, pp. 679-734
Open Access | Times Cited: 477
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
Expert Opinion on Drug Discovery (2016) Vol. 12, Iss. 1, pp. 61-88
Closed Access | Times Cited: 396
Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 12, pp. 963-970
Closed Access | Times Cited: 215
Carbonic Anhydrase Activators
Claudiu T. Supuran
Future Medicinal Chemistry (2018) Vol. 10, Iss. 5, pp. 561-573
Closed Access | Times Cited: 213
Sulfonamides and Their Isosters As Carbonic Anhydrase Inhibitors
Fabrizio Carta, Claudiu T. Supuran, Andrea Scozzafava
Future Medicinal Chemistry (2014) Vol. 6, Iss. 10, pp. 1149-1165
Closed Access | Times Cited: 193
Carbonic Anhydrases and Metabolism
Claudiu T. Supuran
Metabolites (2018) Vol. 8, Iss. 2, pp. 25-25
Open Access | Times Cited: 180
Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 709-712
Open Access | Times Cited: 162
Emerging role of carbonic anhydrase inhibitors
Claudiu T. Supuran
Clinical Science (2021) Vol. 135, Iss. 10, pp. 1233-1249
Closed Access | Times Cited: 156
Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 11, pp. 1175-1197
Closed Access | Times Cited: 147
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
Alessio Nocentini, Andrea Angeli, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 561-580
Open Access | Times Cited: 103
A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 62
A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization
Özen Özensoy Güler, Clemente Capasso, Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2015) Vol. 31, Iss. 5, pp. 689-694
Closed Access | Times Cited: 153
Acetazolamide for the treatment of idiopathic intracranial hypertension
Claudiu T. Supuran
Expert Review of Neurotherapeutics (2015) Vol. 15, Iss. 8, pp. 851-856
Closed Access | Times Cited: 146
Combining Organometallic Reagents, the Sulfur Dioxide Surrogate DABSO, and Amines: A One‐Pot Preparation of Sulfonamides, Amenable to Array Synthesis
Alex S. Deeming, Claire J. Russell, Michael C. Willis
Angewandte Chemie International Edition (2014) Vol. 54, Iss. 4, pp. 1168-1171
Open Access | Times Cited: 146
A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects
Fabrizio Carta, Lorenzo Di Cesare Mannelli, Melissa A. Pinard, et al.
Bioorganic & Medicinal Chemistry (2015) Vol. 23, Iss. 8, pp. 1828-1840
Closed Access | Times Cited: 137
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Metabolites (2020) Vol. 10, Iss. 10, pp. 412-412
Open Access | Times Cited: 137
Carbonic anhydrase inhibition and the management of neuropathic pain
Claudiu T. Supuran
Expert Review of Neurotherapeutics (2016) Vol. 16, Iss. 8, pp. 961-968
Closed Access | Times Cited: 133
Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides
Halise İnci Gül, Mehtap Tugrak, Hiroshi Sakagami, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2016) Vol. 31, Iss. 6, pp. 1619-1624
Open Access | Times Cited: 120
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis
Silvia Bua, Lorenzo Di Cesare Mannelli, Daniela Vullo, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1159-1170
Closed Access | Times Cited: 118
Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 33, Iss. 1, pp. 485-495
Open Access | Times Cited: 114
Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery
Claudiu T. Supuran
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 6, pp. 671-686
Closed Access | Times Cited: 114
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies
Murat Bozdağ, Marta Ferraroni, Elisa Nuti, et al.
Bioorganic & Medicinal Chemistry (2013) Vol. 22, Iss. 1, pp. 334-340
Closed Access | Times Cited: 107
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
Claudiu T. Supuran
Expert Opinion on Drug Metabolism & Toxicology (2016) Vol. 12, Iss. 4, pp. 423-431
Closed Access | Times Cited: 106
Page 1 - Next Page

Scroll to top